A Review on the Efficacy and Safety of Nab-Paclitaxel with Gemcitabine in Combination with Other Therapeutic Agents as New Treatment Strategies in Pancreatic Cancer
Pancreatic cancer has one of the highest mortality rates among cancers, and a combination of nab-paclitaxel with gemcitabine remains the cornerstone of first-line therapy. However, major advances are required to achieve improvements in patient outcomes. For this reason, several research groups have...
Sparad:
Huvudupphovsman: | |
---|---|
Övriga upphovsmän: | , , , |
Materialtyp: | Artículo |
Språk: | en_US |
Publicerad: |
2022
|
Ämnen: | |
Länkar: | https://doi.org/10.3390/life12030327 https://www.mdpi.com/2075-1729/12/3/327/htm |
Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|
Lägg till första kommentaren!